Risk factors for abdominal wall defects.
gastroschisis
hormonal treatment
invasive prenatal diagnostics
omphalocele
risk
Journal
Congenital anomalies
ISSN: 1741-4520
Titre abrégé: Congenit Anom (Kyoto)
Pays: Australia
ID NLM: 9306292
Informations de publication
Date de publication:
Mar 2020
Mar 2020
Historique:
revised:
21
03
2019
received:
07
09
2018
accepted:
22
03
2019
pubmed:
2
4
2019
medline:
2
4
2019
entrez:
2
4
2019
Statut:
ppublish
Résumé
In the last decades, the prevalence of gastroschisis (GS) has increased worldwide. The purpose of this study was to identify maternal risk factors explaining the described gain and to identify differences between GS and omphalocele (OC). A case-control design was used to compare GS (n = 36) and OC (n = 18) mothers to control group (CG; n = 30) matched for maternal age. Specialized questionnaires and mothers' prenatal records were used, and participants completed a structured interview. Focus was on medical history, changing nutrition, drug consumption, and external risk factors. The local ethics committee approved this study. GS mothers were significantly younger (mean 23.00; median 24; SD ±5) than OC (P = 0.007; mean 28.61; median 28, 19-41; SD ±5.1) and CG (P = 0.001; mean 30.77; median 31, SD ±6.2). Mothers with abdominal wall defects (AWD) ingested antibiotics more often (P = 0.008) than CG. Socioeconomic characteristics, for example, level of profession, of GS mothers was significantly lower than OC (P = 0.039) and CG (P = 0.05) mothers, and their cohabitation time was shorter (P < 0.05; mean 35 month/median 24 month, SD ±35.8). Incidence of OC significantly increased after hormonal treatment (P = 0.022) and invasive prenatal diagnostics (P < 0.05) compared to GS. GS mothers took folic acid prophylaxis less often than OC (P = 0.02). Smoking, illicit drugs, and external risks like herbicides showed no influence, but GS mothers drink significantly more often alcohol (P = 0.05). We confirmed an increased risk for GS if several factors such as young maternal age, short cohabitation time, and usage of antibiotics coincide with alcohol consumption and associated immune diseases. OC increased after hormonal treatment and invasive prenatal diagnostics.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
54-61Informations de copyright
© 2019 Japanese Teratology Society.
Références
Richardson S, Browne ML, Rasmussen SA, et al. Associations between periconceptional alcohol consumption and craniosynostosis, omphalocele, and gastroschisis. Birth Defects Res A Clin Mol Teratol. 2011;91(7):623-630.
Hougland KT, Hanna AM, Meyers R, Null D. Increasing prevalence of gastroschisis in Utah. J Pediatr Surg. 2005;40(3):535-540.
Skarsgard ED. Management of gastroschisis. Curr Opin Pediatr. 2016;28(3):363-369.
Jenkins MM, Reefhuis J, Gallagher ML, et al. Maternal smoking, xenobiotic metabolizing enzyme gene variants, and gastroschisis. Risk Am J Med Genet A. 2014;164A(6):1454-1463.
Friedman AM, Ananth CV, Siddiq Z, D'Alton ME, Wright JD. Gastroschisis: epidemiology and mode of delivery, 2005-2013. Am J Obstet Gynecol. 2016;215(3):348 e1-9.
Elliott L, Loomis D, Lottritz L, Slotnick RN, Oki E, Todd R. Case-control study of a gastroschisis cluster in Nevada. Arch Pediatr Adolesc Med. 2009;163(11):1000-1006.
Jones KL, Weiss LA, Hagey LR, Gonzalez V, Benirschke K, Chambers CD. Altered lipid metabolism in gastroschisis: a novel hypothesis. Am J Med Genet A. 2013;161A(8):1860-1865.
Rittler M, Castilla EE, Chambers C, Lopez-Camelo JS. Risk for gastroschisis in primigravidity, length of sexual cohabitation, and change in paternity. Birth Defects Res A Clin Mol Teratol. 2007;79(6):483-487.
Baer RJ, Chambers CD, Jones KL, et al. Maternal factors associated with the occurrence of gastroschisis. Am J Med Genet A. 2015;167(7):1534-1541.
Jones AM, Isenburg J, Salemi JL, et al. Increasing prevalence of Gastroschisis--14 states, 1995-2012. MMWR Morb Mortal Wkly Rep. 2016;65(2):23-26.
Kilby MD. The incidence of gastroschisis. BMJ. 2006;332(7536):250-251.
Loane M, Dolk H, Bradbury I, Group EW. Increasing prevalence of gastroschisis in Europe 1980-2002: a phenomenon restricted to younger mothers? Paediatr Perinat Epidemiol. 2007;21(4):363-369.
Wilson RD, Johnson MP. Congenital abdominal wall defects: an update. Fetal Diagn Ther. 2004;19(5):385-398.
Fratelli N, Papageorghiou AT, Bhide A, Sharma A, Okoye B, Thilaganathan B. Outcome of antenatally diagnosed abdominal wall defects. Ultrasound Obstet Gynecol. 2007;30(3):266-270.
Paranjothy S, Broughton H, Evans A, et al. The role of maternal nutrition in the aetiology of gastroschisis: an incident case-control study. Int J Epidemiol. 2012;41(4):1141-1152.
Groot MJ. Van't Hooft KE. The hidden effects of dairy farming on public and environmental health in The Netherlands, India, Ethiopia, and Uganda, considering the use of antibiotics and other agro-chemicals. Front Public Health. 2016;4:12.
Shariff F, Peters PA, Arbour L, Greenwood M, Skarsgard E, Brindle M. Maternal and community predictors of gastroschisis and congenital diaphragmatic hernia in Canada. Pediatr Surg Int. 2015;31(11):1055-1060.
Marshall J, Salemi JL, Tanner JP, et al. Prevalence, correlates, and outcomes of Omphalocele in the United States, 1995-2005. Obstet Gynecol. 2015;126(2):284-293.
Potzsch S, Hoyer-Schuschke J, Seelig M, Steinbicker V. Knowledge among young people about folic acid and its importance during pregnancy: a survey in the Federal State of Saxony-Anhalt (Germany). J Appl Genet. 2006;47(2):187-190. https://doi.org/10.1007/BF03194620 published Online First: Epub Date.
Feldkamp ML, Reefhuis J, Kucik J, et al. Case-control study of self reported genitourinary infections and risk of gastroschisis: findings from the national birth defects prevention study, 1997-2003. BMJ. 2008;336(7658):1420-1423.
Simeone RM, Feldkamp ML, Reefhuis J, et al. CDC grand rounds: understanding the causes of major birth defects - steps to prevention. MMWR Morb Mortal Wkly Rep. 2015;64(39):1104-1107.
Graham GG, Davies MJ, Day RO, Mohamudally A, Scott KF. The modern pharmacology of paracetamol: therapeutic actions, mechanism of action, metabolism, toxicity and recent pharmacological findings. Inflammopharmacology. 2013;21(3):201-232.
Zhu JL, Basso O, Obel C, Bille C, Olsen J. Infertility, infertility treatment, and congenital malformations: Danish national birth cohort. BMJ. 2006;333(7570):679.
Bergh T, Ericson A, Hillensjo T, Nygren KG, Wennerholm UB. Deliveries and children born after in-vitro fertilisation in Sweden 1982-95: a retrospective cohort study. Lancet. 1999;354(9190):1579-1585.
Dolk H, Loane M, Garne E. The prevalence of congenital anomalies in Europe. Adv Exp Med Biol. 2010;686:349-364.
Fielder HM, Palmer SR, Poon-King C, Moss N, Coleman G. Addressing environmental health concerns near Trecatti landfill site, United Kingdom. Arch Environ Health. 2001;56(6):529-535.
Waller SA, Paul K, Peterson SE, Hitti JE. Agricultural-related chemical exposures, season of conception, and risk of gastroschisis in Washington state. Am J Obstet Gynecol. 2010;202(3):241 e1-241 e6.